tebu-bio is pleased to announce their new partnership for a European distribution of Novabiosis, a US based manufacturer providing cryopreserved primary human cells for the biotechnology, pharmaceutical and medical research fields. Their focus is on Kidney, Intestine, Lung and Liver tissues. They have developed multiple cell types for each organ, an asset for co-culture studies or 3D models development.

Now that the novel coronavirus (2019-nCoV or COVID-19) outbreak has been declared a “public health emergency of international concern” by the WHO, scientists worldwide are being pressured to develop a treatment. The first step of research projects focussing on this virus is to identify robust anti-COVID antibodies.

Some antibodies developed for the 2002 SARS strain present opportunities for immediate deployment while others have been recently made available to the research community. In this post, you’ll find a selection of the most sought after anti-COVID research antibodies.

Chromatin profiling assays enable the mapping of protein-DNA interactions that influence chromatin modeling and gene expression.
Over the years, Chromatin ImmunoPrecipitation (ChIP) assays became the gold-standard for studying transcription factor–DNA binding interactions, nucleosome dynamics, and epigenetics (ex. histone post-translational modifications (PTMs)). This post aims at introducing the latest evolution of ChIP assays: CUTANA CUT&RUN and ChIC assays.

Over the last years, ChIP experts express the need for more sensitivity, faster protocols, and more reproducible results (and ideally starting from less starting cellular material). These expectations led to the emergence of new experimental antibody-based experimental approaches like Chromatin ImmunoCleavage (ChIC) assays, and Cleavage Under Targets and Release Using Nuclease (CUT&RUN) methods.

Time-Resolved Förster Resonance Energy Transfer (TR-FRET) is a robust and homogeneous fluorescence detection technology and a real alternative to classical ELISA and Western Blot to perform Cell Signalling studies. Based on this improved TR-FRET technology, tebu-bio is pleased to introduce a new product line of high-quality, fully-validated and affordable kits. These ready-to-use Thunder™ kits enable sensitive, simple and rapid measurement of low amounts of specific intracellular phosphorylated and total proteins in cell lysates from adherent or suspension cells.

The main features of these new Thunder™ TR-FRET kits are presented in this post.

How does it work?

Even though based on the traditional immuno-assay sandwich principle, the kits use a streamlined protocol wherein the antibody-target sandwich complex is formed in solution in a single addition and incubation step, without any wash steps. This protocol dramatically decreases hands-on time (5 minutes) and enables faster time to results (1-4 hours).

After lysis steps, a pair of antibodies specific for the target protein is added to the lysate sample (Fig.1). One antibody is labeled with a donor fluorophore (a Europium chelate), while the second antibody is labeled with an acceptor fluorophore (a far-red dye). Upon excitation of the Europium chelate at 320 or 340 nm, energy is transferred from the donor to the acceptor fluorophore if they are sufficiently close (within 10 nm) for FRET. This results in the emission by the acceptor of a TR-FRET signal at 665 nm.

Why is THUNDER TR-FRET a smart solution for cellular studies?

OPTIMAL ANTIBODY PAIR SELECTION

• Validated antibodies were selected to guarantee specificity for the target protein.
• Many donor/acceptor fluorophores were tested to select the optimal pair providing the best TR-FRET signal-to-background.
• Extensive testing of labeled antibody pairs using optimized lysis buffers followed by assay optimization were conducted to ensure specificity, reproducibility and optimal TR-FRET assay performance.

RIGOROUS VALIDATION

All Thunder™ kits are subjected to a stringent validation process using lysates from cells that are treated with pathway-specific activators and inhibitors to further confirm target specificity.

CONFIRMED LOT-TO-LOT CONSISTENCY

All Thunder™ kits are developed, validated and manufactured to ensure lot-to-lot consistency using a functional quality control assay where each new lot is compared to the previous lot.

AFFORDABILITY

Thunder™ is an affordable cell-based assay platform that provides easy access to the TR-FRET technology for all researchers looking to quantify low amounts of endogenous proteins in cells.

Assay workflow

All it takes is 3 simple steps to complete the workflow of all the TR-FRET Cell Signaling Assays.

Assays can be run using a 2-plate (transfer) protocol:

Or a 1-plate (all-in-one-well) protocol:

Assays are optimized to be run in 96-well or 384-well plates using the same total volume (20µL).

Typical validation data

Most popular targets

• AKT (pan)
• EGFR : Epidermal Growth Factor
• STAT6 : Signal Transducer and Activator of Transcription 6
• IL-2 & IL-6: Human Interleukin 2 & 6
• IFNγ : Human Interferon Gamma
• cAMP : adenosine 3′,5′-cyclic monophosphate

Discover all THUNDER kits available

• Cell Signalling Assay Kits : Simple and rapid detection of either a specific phosphorylated target protein (Phospho-protein kit) and/or total protein in cell lysates (Total protein kit)
• Biomarker Assay Kits : Assay developed to easy and quickly quantitate pro-inflammatory human cytokines in cell supernatants
• cAMP Assay Kits : Assay kit provide a simple, rapide, robust and affordable tool to measure intracellular cAMP changes following G-protein coupled receptor (GPCR) activation.

Try a real alternative to perform your cell signalling studies in a different way!